SpaceX's $116 Billion Lockup Cliff: The Largest Supply Test in Modern Market History

On Thursday, August 6, 2026 — two trading days after SpaceX reports its first quarterly results as a public company — approximately 911.5 million shares will become eligible for sale. At SpaceX’s August 3 closing price of $114.53, that tranche is worth roughly $116 billion. It is, by any measure, the largest single stock-unlock event in modern market history, and it is only the first of sixteen scheduled release dates running through December.^[1][2]

The numbers are worth sitting with. SpaceX’s IPO on June 12, 2026 raised more capital than any initial public offering ever — the stock closed its first session at $161, up 19%, valuing the company at $2.1 trillion.^[2] It then rocketed to an intraday peak near $225 on June 16 before giving back more than half its value. As of the August 3 close, SPCX sat at $114.53, up 5.68% on the day but down roughly 50% from its high.^[3] The 52-week low of $104.83 was set that same session.^[3]

What makes the August 6 unlock unusual is its structure. SpaceX’s prospectus ties each tranche release to the earnings calendar rather than a fixed calendar date. Two trading days after the first quarterly report — scheduled for Tuesday, August 4 — roughly 20% of locked shares become sellable.^[4] That first wave alone totals ~911.5 million shares, exceeding the estimated $86 billion in shares currently constituting SpaceX’s public float.^[4] Every subsequent month brings another unlock, meaning the supply pressure is not a one-day event but a grinding, month-by-month release schedule that extends into late 2026.^[4]

The Earnings-Lockup Collision

The timing is deliberate but brutal. SpaceX reports its first-ever public quarterly results on August 4. Whatever the print — Starlink revenue trajectory, launch cadence margins, capital expenditure guidance — the market has barely 48 hours to digest it before the supply floodgates open. HSBC, which has mapped the full unlock schedule, notes that the August 6 tranche alone could cap any post-earnings bounce and keep pressure on the stock into September, regardless of Starship’s operational progress.^[2]

This is the core tension: the fundamental thesis on SpaceX (launch dominance, Starlink scaling, AI infrastructure optionality) will be tested on August 4, but the market structure thesis — can the float absorb the supply? — does not fully resolve for months. A strong earnings print could be swallowed by selling pressure from employees and early investors who have watched their paper gains evaporate from $225 to $110. A weak print could accelerate the rush to the exits.

A Record Issuance Year

SpaceX’s lockup cliff does not arrive in isolation. US equity issuance reached approximately $700 billion in 2026, combining IPOs, secondary offerings, convertible bonds, and SPACs — a historic high, according to Goldman Sachs analysis.^[5][6] Goldman Sachs Chief US Equity Strategist Ben Snyder notes that this figure represents only about 1% of Russell 3000 market capitalization, matching the 2015–2019 average and remaining below 2021’s approximately 1.5% and the dot-com boom peak of 2%.^[5]

The offsetting force is corporate demand. Buyback announcements have totaled $960 billion year-to-date, with Goldman Sachs projecting full-year buyback volume at approximately $1.3 trillion. NVIDIA alone recently increased its buyback authorization by $80 billion.^[5] Snyder characterizes this as “sufficient to offset the combined potential supply from direct corporate issuance and lockup expirations” for 2026.^[5]

But the forward picture is less comfortable. “The math becomes more difficult in 2027 when lockups for stocks listed in 2026 expire,” Snyder said, adding that “the supply-demand balance is clearly moving in a negative direction.”^[5] Jay Ritter, Professor Emeritus at the University of Florida, offers a counterweight: “given the overall size of the US stock market, the likelihood of serious indigestion remains low.”^[5] Ritter notes that US listed companies pay about $600 billion in annual dividends and about $1 trillion in buybacks, against $1.6 trillion in cash needing reinvestment annually.^[5]

The IPO Pipeline: Not Just SpaceX

While SpaceX dominates the supply narrative, the broader IPO calendar tells a story of a market that is absorbing new listings at a brisk but not runaway pace:

• Jersey Mike’s Subs (JMKE) — Priced at $23 on the NYSE on July 30, raising approximately $1 billion and valuing the sandwich chain at $7.3 billion. Shares opened at $21, 8.7% below the IPO price, and closed the first day down roughly 6%.^[7] By Friday August 1, the stock had rebounded to $23, recovering its first-day decline.^[7]
• Attovia Therapeutics (ATTO) — A Phase 1 biopharmaceutical company developing nanobody-based therapeutics for immune-mediated diseases, headquartered in San Carlos, California. Set to list on Nasdaq on August 5, offering 12.5 million shares at $15–$17 to raise up to $212.5 million.^[1]
• Apnimed (APMD) — Priced July 31 at $16, 12 million shares, $192 million deal size, led by BofA Securities, Evercore ISI, Cantor, and LifeSci Capital.^[8]
• Churchill Capital XIII (XIIIU) — A SPAC pricing 36 million units at $10 on July 31, raising $360 million.^[8]
• Ionic Digital (IOND) — Listed on Nasdaq on July 28, offering 10.8 million shares with reported revenue of $151.76 million.^[8]

Investment manager Ninety One has separately warned that the SpaceX-led listing boom could reverse what it calls the “de-equitisation tailwind” — the multi-year trend of companies shrinking their share counts through buybacks — that has supported US equity returns for over two decades.^[9] The concern is that record issuance dilutes that effect, even if buybacks remain large in absolute terms.

What the Base Rates Say

Here is where the forecasting gets interesting. The historical analogy that most directly applies is not 2021 — when IPO issuance spiked to ~1.5% of Russell 3000 market cap and many deals traded poorly — but rather the large-cap lockup expirations of the past decade (Facebook in 2012, Uber and Lyft in 2019, Snowflake in 2021). In each case, the unlock created measurable but temporary selling pressure. The stock typically underperformed in the weeks surrounding the expiry, then recovered as the supply was absorbed.

SpaceX is different in degree if not in kind. A $116 billion unlock against an $86 billion existing float means the supply shock is structurally larger — the ratio of new-to-existing tradable shares is roughly 1.35x, whereas most historical lockup expirations released shares equal to 20–50% of the float. But the monthly tranche structure, rather than a single cliff, means the market gets partial price discovery at each date rather than a one-day liquidation.

Goldman’s self-correction thesis is worth taking seriously: if supply pressure pushes newly listed stocks down hard enough to deter future issuance, the pipeline narrows, and the imbalance partially resolves itself.^[5] The IPO calendar for the weeks after August 6 is notably thin — Renaissance Capital shows “nothing on the IPO calendar looking ahead” beyond the current week’s deals.^[8] That is consistent with a market that prices new supply cautiously.

What to Watch Next

1. August 4 — SpaceX Q2 earnings. The first public read on Starlink revenue, launch margin, and capex guidance. Whether the print beats or misses consensus matters less for the immediate supply picture than for whether early investors feel urgency to sell into strength or weakness.

2. August 6 — First lockup tranche (~911.5 million shares). Watch volume, not just price. If the first-day unlock volume exceeds 2–3x the stock’s recent average daily volume (~69 million shares on August 3), that signals aggressive absorption rather than panic. If price holds above the $104.83 52-week low on heavy volume, the market is digesting supply. If it breaks below on expanding volume, the next tranches arrive into a weaker tape.

3. Subsequent monthly unlocks (September–December). Each tranche provides incremental price discovery. The pattern to watch for is whether each subsequent unlock produces diminishing price impact — a sign that the marginal seller has already exited — or escalating pressure, which would indicate the market has not found a clearing price.

4. 2027 lockup expirations across 2026 IPOs. Goldman’s Snyder flags this as the harder math: the cumulative supply from all 2026 IPO lockups expiring next year, set against a buyback pipeline that may or may not maintain its $1.3 trillion pace. If AI-related capex continues to crowd out buyback capacity, as Deutsche Bank has warned it might, the supply-demand balance deteriorates further.^[9]

5. The IPO pipeline response. If post-lockup trading in SpaceX and other 2026 listings is disorderly enough to suppress new filings, that is the self-correction mechanism working. A thin fall IPO calendar would be evidence the market is rationing supply. A crowded calendar would suggest issuers are racing to beat the 2027 lockup wall.

The honest forecast is this: the probability that the August 6 unlock produces sharp but temporary volatility, followed by gradual absorption over the following months, sits at roughly 60%. The alternative — that the first tranche breaks the stock below its lows and the subsequent monthly unlocks cascade — is a 40% scenario that depends heavily on the earnings print and on whether early investors are price-sensitive or motivated sellers. Either way, the supply test that begins August 6 is the market-structure event of the year, and its resolution will shape how investors price every 2026 IPO that follows.